1) falciparum malaria
恶性疟
1.
An investigation report of the first death case of falciparum malaria in Dalian;
大连地区首例恶性疟死亡个案调查报告
2.
Objective To study the malaria epidemic characteristics and control measures, so as to control malaria and eradicate falciparum malaria in Guangxi Autonomous Region of China.
目的 研究广西疟疾流行特征及防治措施 ,控制疟疾流行和消灭恶性疟。
3.
Methods each of 48 cases of falciparum malaria in group A were treated with total dosage of 200 mg artesunate plus 400 mg naphthoquine for 2 days, and each of 57 cases in group B were given total dosage of artesunate 300 mg and naphthoquine 600 mg for 3 days.
目的 研究青蒿琥酯、萘酚喹不同联用方案治疗抗药性恶性疟的效果。
2) Plasmodium falciparum
恶性疟
1.
Evaluation of results of ACON Malaria p.f./p.v.Gold Immunochromotographic Kit in diagnosis of Plasmodium falciparum and Piasmodium vivax;
艾康恶性疟/间日疟免疫层析检测试剂盒效果评价
2.
Study on epidemic and control of Plasmodium falciparum in Anhui;
安徽省恶性疟流行与防治的研究
3.
Endogenous family outbreak of Plasmodium falciparum in winter
一起冬季内源性恶性疟家庭暴发的调查
3) Falciparum malaria
恶性疟疾
1.
Artesunate for 321 patients with falciparum malaria in the Republic of Mali;
青蒿琥酯治疗在马里共和国的恶性疟疾321例
2.
Clinical and immunologic regulation on Dihydroartemisinin in falciparum malaria;
双氢青蒿素对恶性疟疾的疗效及免疫调节作用观察
3.
To observe the clinical efficacy of compound artemether in patients with Falciparum malaria,Patients with Plasmodium falciprum were selected and treated with compound artemether by the administration of 4 times in 3 days, administered 4 pieces at first, and 8,24,and 48 hours later, totals 16 pieces.
可见复方蒿甲醚治疗恶性疟疾具有良好的临床效果。
4) Plasmodium falciparum malaria
恶性疟疾
1.
Clinical analysis of 65 baby and infant cases with Plasmodium falciparum malaria;
非洲婴幼儿恶性疟疾65例临床分析
2.
Observation on the therapeutic effect of Quinimax on Plasmodium falciparum malaria in Africa;
Quinimax治疗非洲恶性疟疾的临床疗效研究
3.
Objective To assess the therapeutic efficacy of dihydroartemisinin -piperaquine tablet,(trade name : Ketaifu,40/320mg) made in China in treatment of Plasmodium falciparum malaria.
目的观察国产双氢青蒿素哌喹片治疗恶性疟疾的临床效果。
5) severe and complicated falciparum malaria
重症恶性疟
6) Plasmodium falciparum
恶性疟原虫
1.
Analysis on the correlation between chloroquine resistance and pfmdr-1 gene in Plasmodium falciparum isolates from Hainan province;
恶性疟原虫海南分离株pfmdr1基因与氯喹抗性的相关性分析
2.
Regulation Mechanism of Variation in Plasmodium falciparum Var Gene Family;
恶性疟原虫Var基因家族的变异调控机制
3.
Establishment of model of Plasmodium berghei transfected with Plasmodium falciparum apical membrane antigen-1 gene;
恶性疟原虫顶端膜抗原1基因转染伯氏疟原虫模型的建立
补充资料：恶性疟
恶性疟
malignant malaria
疟原虫引起的传染病，有引起疟疾病凶险发作的可能，传播媒介是雌性按蚊。临床症状复杂而多样化。发热前寒战较少，可仅有畏寒，头痛、肌痛、恶心、呕吐、烦渴等症状较显著。热型多不规则。贫血和脾肿大显著，重症有黄疸和肝功能损害，并易致凶险发作。一般治疗同其他传染病。控制临床发作，可选用消灭病原体的药物如氯喹、奎宁、磷酸咯啶、磷酸咯萘啶、甲氧苄胺嘧啶等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条